Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

956
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
956
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
Seizures: Classification01:13

Seizures: Classification

2.2K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.2K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.0K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.0K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.3K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation Between Quantitative Pupillometry and Other Markers for Neuroprognostication of Comatose Patients After Cardiac Arrest: A Bicentric Study.

Critical care medicine·2026
Same author

Status Epilepticus Is Detected Earlier than Seizures on cEEG in Critically Ill Adults.

Neurocritical care·2026
Same author

Effects of midazolam and propofol on EEG detection of epileptiform activity in patients with altered consciousness.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring.

Critical care medicine·2026
Same author

Brainstem Respiratory Center Dysfunction in Persons With Epilepsy: An fMRI Study.

Neurology·2026
Same author

Relevance of EEG recording time for juvenile myoclonic epilepsy diagnosis confirmation: a reappraisal.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026

Related Experiment Video

Updated: Mar 29, 2026

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

26.4K

Should Postanoxic Status Epilepticus be Treated Aggressively?-No!

Andrea O Rossetti1

  • 1Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne, Lausanne, Switzerland.

Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society
|December 3, 2015
PubMed
Summary

Status epilepticus and myoclonus are common after cardiac arrest. Treatment decisions for these seizures depend on whether they occur during therapeutic hypothermia or after rewarming, impacting patient prognosis.

More Related Videos

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.3K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

12.2K

Related Experiment Videos

Last Updated: Mar 29, 2026

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

26.4K
Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
08:28

Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus

Published on: April 5, 2011

18.3K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

12.2K

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Cardiology

Background:

  • Electrographic status epilepticus and myoclonus are frequent in cardiac arrest survivors.
  • These neurological events are associated with poor clinical outcomes.
  • The timing of these events (during hypothermia vs. after rewarming) may influence prognosis.

Purpose of the Study:

  • To differentiate the prognostic implications of status epilepticus and myoclonus based on their occurrence during therapeutic hypothermia versus after rewarming.
  • To inform treatment strategies for post-cardiac arrest neurological complications.

Main Methods:

  • Review of existing data on neurological findings in cardiac arrest survivors.
  • Analysis of outcomes related to status epilepticus and myoclonus.
  • Correlation of seizure occurrence with therapeutic hypothermia and normothermic conditions.

Main Results:

  • Status epilepticus during therapeutic hypothermia and sedation is invariably associated with a fatal outcome.
  • Status epilepticus and/or myoclonus occurring after return to normothermia may have a different prognosis.
  • Some patients presenting seizures after rewarming may benefit from antiepileptic treatment.

Conclusions:

  • Aggressive treatment of status epilepticus during hypothermia appears futile.
  • Patients with status epilepticus or myoclonus after rewarming, especially with favorable prognostic markers, may warrant antiepileptic treatment and a chance for awakening.